rapid emerge subset spread novel influenza ahn virus hn prompt world health organ declare first tandem st century highlight threat public healthcare system widespread resist class antivirus adamant neuraminidas inhibitor occur season virus render drug margin until treatment modal worldwide virtual strain resist rimantadin amantadin major oseltamivir wide prescribe inhibitor nai address need effect therapy value vitro active trial combine antivirus drug cad regimen compose differ meghan action drugresist ribavirin along test oseltamivirresist use infect model mock cell data show highly synergist synergy significantly greater double p include two nai surprisingly contribute respect content single agent clinic achieve demons overcome baseline approve thu may metres active 